Osteoblast differentiation via BMP-SMAD signaling pathway

The “Osteoblast differentiation via BMP-SMAD signaling pathway” refers to the process by which bone morphogenetic proteins (BMPs), a subset of the TGF-β superfamily of ligands, promote the differentiation of precursor cells into osteoblasts via activation of intracellular SMAD proteins. BMPs bind to heterotetrameric complexes of BMP type I (e.g., ALK2, ALK3, ALK6) and type II (BMPR2, ActR-2A, ActR-2B) receptors on the cell surface, leading to phosphorylation of receptor-regulated SMADs (mainly SMAD1, SMAD5, SMAD8). These then complex with the common mediator SMAD4, translocate to the nucleus, and regulate transcription of target genes crucial for osteoblast development and function (e.g., Runx2, Osterix)[3][5][7][8]. Pathway dysregulation is implicated in disorders such as impaired bone formation, cancer, and iron homeostasis abnormalities[2][1].

Other names

BMP-SMAD pathwayBone morphogenetic protein signalingBMP signaling

Ligand binding (BMPs bind to BMP receptors) leading to SMAD phosphorylation and nuclear transcriptional activation\nModulation of SMAD signaling (induction or inhibition of R-SMAD and co-SMAD complexes)